Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial
about
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinomaCancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.
P2860
Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hypertension and Circulating C ...... Results From a Phase II Trial
@ast
Hypertension and Circulating C ...... Results From a Phase II Trial
@en
type
label
Hypertension and Circulating C ...... Results From a Phase II Trial
@ast
Hypertension and Circulating C ...... Results From a Phase II Trial
@en
prefLabel
Hypertension and Circulating C ...... Results From a Phase II Trial
@ast
Hypertension and Circulating C ...... Results From a Phase II Trial
@en
P2093
P2860
P1433
P1476
Hypertension and Circulating C ...... Results From a Phase II Trial
@en
P2093
Aarif Yusuf Khakoo
Alper Y Kearney
Amado J Zurita
Eric Jonasch
Hsiang-Chun Chen
Mehmet Asim Bilen
Nasreen A Ilias-Khan
Nizar M Tannir
Sherie Hodges
Shixia Huang
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0143
P577
2015-08-25T00:00:00Z